The price-to-earnings ratio for Sensus Healthcare Inc (NASDAQ: SRTS) is 12.85x, which is above its average ratio. Moreover, the 36-month beta value for SRTS is 1.20. Analysts have varying opinions on the stock, with 1 analysts rating it as a “buy,” 3 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for SRTS is 13.17M and currently, short sellers hold a 4.43% of that float. On December 27, 2024, SRTS’s average trading volume was 174.58K shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
SRTS) stock’s latest price update
Sensus Healthcare Inc (NASDAQ: SRTS) has seen a rise in its stock price by 7.94 in relation to its previous close of 6.80. However, the company has experienced a -0.81% decline in its stock price over the last five trading sessions. zacks.com reported 2024-12-20 that In the latest trading session, Sensus Healthcare, Inc. (SRTS) closed at $7.10, marking a -1.53% move from the previous day.
SRTS’s Market Performance
Sensus Healthcare Inc (SRTS) has experienced a -0.81% fall in stock performance for the past week, with a -16.40% drop in the past month, and a 27.65% rise in the past quarter. The volatility ratio for the week is 6.39%, and the volatility levels for the past 30 days are at 5.31% for SRTS. The simple moving average for the past 20 days is -9.34% for SRTS’s stock, with a 25.35% simple moving average for the past 200 days.
Analysts’ Opinion of SRTS
Many brokerage firms have already submitted their reports for SRTS stocks, with Maxim Group repeating the rating for SRTS by listing it as a “Buy.” The predicted price for SRTS in the upcoming period, according to Maxim Group is $14 based on the research report published on November 15, 2024 of the current year 2024.
SRTS Trading at -2.93% from the 50-Day Moving Average
After a stumble in the market that brought SRTS to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -21.32% of loss for the given period.
Volatility was left at 5.31%, however, over the last 30 days, the volatility rate increased by 6.39%, as shares sank -14.75% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +14.33% upper at present.
During the last 5 trading sessions, SRTS fell by -0.81%, which changed the moving average for the period of 200-days by +106.76% in comparison to the 20-day moving average, which settled at $8.10. In addition, Sensus Healthcare Inc saw 211.02% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at SRTS starting from Heinrich John, who sale 15,227 shares at the price of $6.24 back on May 20 ’24. After this action, Heinrich John now owns 59,940 shares of Sensus Healthcare Inc, valued at $95,016 using the latest closing price.
Heinrich John, the Director of Sensus Healthcare Inc, sale 4,773 shares at $5.95 during a trade that took place back on May 17 ’24, which means that Heinrich John is holding 75,167 shares at $28,399 based on the most recent closing price.
Stock Fundamentals for SRTS
Current profitability levels for the company are sitting at:
- 0.29 for the present operating margin
- 0.61 for the gross margin
The net margin for Sensus Healthcare Inc stands at 0.23. The total capital return value is set at 0.22. Equity return is now at value 18.86, with 16.87 for asset returns.
Currently, EBITDA for the company is 79000.0 with net debt to EBITDA at -1.77. When we switch over and look at the enterprise to sales, we see a ratio of 2.38. The receivables turnover for the company is 2.44for trailing twelve months and the total asset turnover is 0.69. The liquidity ratio also appears to be rather interesting for investors as it stands at 10.52.
Conclusion
To wrap up, the performance of Sensus Healthcare Inc (SRTS) has been mixed in recent times. The stock has received a bullish of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
